Market research in action
July 19, 2004Market research is to marketing as water is to life. This deeply held view is rooted in the personal belief …
Framework to promote pharma-NHS partnerships launched
July 15, 2004A framework to facilitate greater collaboration between the pharma industry and the NHS has been launched by the ABPI in …
Vaccine to help smokers kick the habit shows promise
July 15, 2004A vaccine designed to help smokers kick the habit has shown promise in its second phase I trial, boosting shares …
AstraZeneca appoints new global head of product PR
July 15, 2004AstraZeneca has appointed a new head of global public relations to oversee strategic public relations programmes and all other aspects …
Pfizer seizes initiative with US drug discount programme
July 15, 2004Pfizer will offer drug discounts to the 43 million Americans without health insurance as it seeks to rebuild its image …
Lilly’s ‘Cialis Promise’ increases pressure on Viagra
July 15, 2004The battle for erectile dysfunction market dominance is intensifying in the US with Lilly using consumer-style promotional offers to help …
Atacand filed for heart failure in US
July 8, 2004AstraZeneca has submitted its cardiovascular drug Atacand for an additional US licence to treat heart failure.Atacand (candesartan) is one of …
Pfizer’s next blockbuster Lyrica receives European approval
July 8, 2004Pfizer's potential central nervous system blockbuster Lyrica (pregabalin) has received European marketing approval.The drug has received licences for the treatment …
Pfizer UK recruiting for new customer-focused salesforce
July 8, 2004NHS, Pfizer, salesforce
Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …
Everyday diseases and everyday solutions
July 8, 2004What is all the fuss about chronic disease management? Go to virtually any NHS conference these days and you will …
Growing doubts over reliability of HRT trial conclusions
July 6, 2004Influential publicly-funded trials into HRT which convinced millions of women to stop taking the treatment could be flawed, researchers from …
Labour stakes its reputation on NHS Plan part II
July 6, 2004The government has unveiled a plan for the second half of the 10-year period covered by the NHS Plan, claiming …
Unveiled: how to win their attention
July 2, 2004Sir Arthur Conan Doyle once wrote: "It is a capital mistake to theorise before one has data. Insensibly one begins …
Takeda to launch ‘radically different’ approach to NHS
July 2, 2004NHS, Takeda, salesforce
Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …
Novartis rivals find VALUE in landmark Diovan trial
July 1, 2004A landmark study comparing Novartis' Diovan with Pfizer's calcium channel blocker Istin has ended with both sides claiming superiority for …
Pharma’s reputation continues to slide
July 1, 2004The reputation of the pharmaceutical industry in the US continues to decline as the public grows increasingly concerned about the …
